Epithelial Mesenchymal Transition in Aggressive Lung Cancers
Author:
- 25 December 2015
- book chapter
- Published by Springer Nature
- Vol. 890, 37-56
Abstract
The progression of a cancer cell into a metastatic entity contributes to more than 90 % of cancer related deaths. Therefore, the prevention and treatment of metastasis is an unmet clinical need. Epithelial to mesenchymal transition (EMT) is an evolutionary conserved developmental program, which is induced during cancer progression and contributes to metastatic colonization. EMT endows metastatic properties upon cancer cells by enhancing mobility, invasion, and resistance to apoptotic stimuli. Furthermore, EMT-derived tumor cells acquire stem cell properties and exhibit therapeutic resistance. The disseminated tumor cells recruited to distant organs are suggested to subsequently undergo an EMT reversion through mesenchymal to epithelial transition (MET), necessary for efficient colonization and macrometastasis. A major focus of cancer research is to determine the cellular and molecular mechanisms underlying EMT/MET in tumor invasion, dissemination and metastasis. In this chapter, we will focus on the contribution of the EMT signaling pathways in lung cancer progression, cancer stem cells and acquired resistance to EGFR tyrosine kinase inhibitors and chemotherapy. We will also discuss the potential of targeting EMT pathways as an attractive strategy for the treatment of lung cancer.Keywords
This publication has 144 references indexed in Scilit:
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Periostin expression and epithelial-mesenchymal transition in cancer: a review and an updateVirchows Archiv, 2011
- Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancerBritish Journal of Cancer, 2011
- The Inflammatory Tumor Microenvironment, Epithelial Mesenchymal Transition and Lung CarcinogenesisCancer Microenvironment, 2011
- Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?International Journal of Cancer, 2011
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the BreastCell, 2011
- A systems view of epithelial–mesenchymal transition signaling statesClinical & Experimental Metastasis, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008